The course will cover reptiles, pet mammals and captive birds.
Marie says the course will teach you how to approach exotic emergencies confidently, from clinical examination and forming differential diagnoses to medical and surgical approaches for common emergency presentations.
Marie will discuss both clinical management and the stabilisation and care of the critical patient, including fluid therapy, analgesia, contra-indicated medications and hospital cage requirements.
Welfare-focused euthanasia approaches will also be covered for different species.
Tickets cost £300 and the course is open to veterinary surgeons, veterinary nurses and students on a recognised veterinary or nursing course.
Lunch, tea, coffee and biscuits included.
https://evolutionexoticsreferrals.co.uk/cpd-booking-form/
Genitrix has launched a new system called Osteokine, which produces Platelet-Rich-Plasma (PRP). PRP, an autologous solution containing therapeutically significant concentrations of platelets, is known to accelerate the healing of injuries and is already widely used in human medicine. It is increasingly being used in the treatment of horses.
The Osteokine system, developed by German company Orthogen which also manufactures joint therapy Irap, comprises two interconnected blood bags.
The system involves taking citrated whole blood from the horse and placing it into the first, red-capped Osteokine bag for processing in a centrifuge. The plasma and platelets are then transferred to the second bag, and a second centrifuge process separates the plasma and generates a pellet of PRP, which is extracted and used to treat the horse from which it was taken.
Treatment with PRP has been shown to accelerate wound healing in all kinds of tissue particularly tendons and ligaments and has also been used in bone healing. It has been noted to reduce perioperative traumatic pain while the higher collagen content provided by PRP can create improved scar resistance.
Commenting on the launch of the Osteokine system in the UK, Rob Watkins, Marketing Director of Genitrix, said: "Therapeutic care of equine lameness is an area of particular expertise for Genitrix and the innovative treatments we've brought to market, including Acell, HY50 and Irap already form part of the staple ‘toolkit' of many equine vets.
"The benefits of PRP in terms of accelerating wound healing and vasculerisation are already widely accepted as are the advantages of an autologous approach in terms of eliminating the risk of disease transmission. To date, however, the process of extracting PRP has proved complex and expensive and only provided in specialised laboratories.
"Osteokine, in contrast, offers a cost-effective approach based on a system which is simple to operate in practice and takes only 20 minutes. We believe it offers a highly effective approach to treating wounds and injuries in horses."
For further information on Osteokine, contact Genitrix on 01403 786345.
New Horse Passport Guidelines come into force from 1 July 2009 which will require horses to be microchipped. However a recent poll on Horse & Hound Online has revealed that 75 per cent of those questioned were unaware of the new microchip legislation.
With this in mind, Bayer has produced a comprehensive marketing support package for equine vets which provides an overview of the new Horse Passport Guidelines 2009 together with a clear and concise summary of its requirements for vets and horse owners.
The Tracer Advance equine package contains a handy laminated bullet point guide to the new regulations, practice posters, client leaflets, client leave pieces, pre-written articles for use in practice newsletters and local press, and PowerPoint presentations for client evenings.
Practices can apply for any of these items by contacting their Bayer Territory Manager.
The RCVS has released the results of a survey it conducted which has found that the vast majority of recent graduates from UK veterinary schools consider extra-mural studies (EMS) to be an essential component of the veterinary degree.
The survey was launched earlier this year in order to help the RCVS build up a picture of how EMS placements are currently working and whether graduates felt that they had gained knowledge and experience from placements that they could not have learnt from their core studies. Some 287 veterinary graduates from 2012 and 2013 participated in the survey, the overwhelming majority of whom (95.6%) agreed that EMS was essential.
Furthermore, the majority of the recent graduates said that they had found EMS placements to be beneficial in terms of the variety of clinical skills, professional skills and working practices they encountered. The only area in which a large number of graduates (42.9%) said that they did not find EMS placements useful was in gaining experience of out-of-hours and weekend work.
Despite the overall positive results, however, a number of concerns about EMS were raised. Issues included variable quality of placements; significant numbers of respondents feeling they were not able to gain as much 'hands-on' experience from placements as they would like; costs of accommodation and travel; and a lack of farm/mixed animal practices for placements.
Other key findings included the fact that the vast majority of veterinary students identified and booked their own placements at EMS practices and that their placements were at the type of practice they were looking for.
Christine Warman, RCVS Head of Education, said: "We launched this survey as an information-gathering exercise to see how EMS placements are currently working, following our last review of EMS in 2009 - and the results have certainly been very interesting.
"What is clear is that the current system is working well and that there is no need for an immediate review or urgent action. Most graduates found the experience gained on placements useful for their studies and find that EMS sets them up well for their first job in practice.
"However, there are a number of issues that we will keep a watching brief over and we plan to repeat the survey every two years in order to monitor these."
The full results of the survey are available to view at www.rcvs.org.uk/emssurvey2014. Detailed guidance on EMS placements for students, university staff and EMS practices is also available at www.rcvs.org.uk/ems.
Any queries about EMS can also be directed to the RCVS Education Department on education@rcvs.org.uk or 020 7202 0704.
Zoetis has released new surveillance results which show that Mycoplasma bovis is becoming an increasingly significant pneumonia pathogen in cattle1.
In more than 2,500 samples submitted by vets for analysis during 2014, 45% were positive, compared with 41% in 2013.
According to Dr Tim Potter MRCVS from Westpoint Veterinary Group, Mycoplasma bovis has emerged as an important pathogen of calves worldwide2. He said: "It is associated with a number of clinical presentations including respiratory disease, otitis media and arthritis.
"The role of Mycoplasma bovis in pneumonia is well established and there are a number of reports in the literature of respiratory disease outbreaks where it was the predominant bacterium isolated. However, as with most causes of pneumonia, colonisation by Mycoplasma bovis alone is not always sufficient to cause disease and it may present in combination with other respiratory pathogens."
For other pathogens, the surveillance found 83% of samples positive for Para-influenza 3 virus (Pi3v), 76% Bovine Respiratory Syncytial virus (BRSv), 32% IBR, and 25% for BVD. Apart from BVD, which saw a three-point reduction from 28% the previous year - these show little change from 2013.
According to Zoetis vet Carolyn Hogan, in pneumonia outbreaks involving Mycoplasma bovis, many of the clinical signs are similar to those caused by other pneumonia pathogens: coughing, raised temperature, rapid breathing and lethargy.
She said: "This can make it difficult for farmers and vets alike to identify Mycoplasma bovis as a possible cause of disease based on clinical signs alone, unless calves are also showing some of the other distinguishing signs associated with Mycoplasma infection.
"These include ear infections, head shaking or tilting, and arthritis. Poor response to treatment, with resulting chronic respiratory cases, may also be suggestive of Mycoplasma infection. For a definitive diagnosis, of course, analysis of blood or respiratory tract mucous is required."
Whilst vaccination protection is available against the viruses (BRSv, Pi3v, BVD and IBR) and Mannheimia (Pasteurella) haemolytica, Carolyn points out that there is no ‘off the shelf’ vaccine available for Mycoplasma bovis. She adds that treatment can be challenging due to the insidious nature of disease, and lack of effectiveness of some antibiotics.
Once Mycoplasma bovis is present on a farm, Carolyn cautions that eradication can be very difficult. "It can be transmitted in milk from carrier cows, and in saliva among calves, particularly when multiple animals suckle the same teat feeders.
"Minimising this pathogen's impact on health and productivity relies on reducing its exposure to susceptible animals and maximising their resilience against it. For a comprehensive programme of control measures, farmers should consult their vet."
Carolyn suggests that such a programme is likely to include: testing the farm's Mycoplasma bovis status; effective biosecurity; not feeding infected milk; ample ventilation for adults and youngstock alike; rapid spotting of sick animals, isolation and vet-prescribed treatment; vigilance for poor response to treatment and development of chronic cases; vaccination against main viral pneumonia pathogens; and low stress through good stockmanship.
References
Photo: By Y tambe (Y tambe's file) [GFDL, CC-BY-SA-3.0 or CC BY-SA 2.5-2.0-1.0], via Wikimedia Commons
Dechra Veterinary Products, manufacturer and distributor of Equipalazone®, has launched a new information leaflet to support the Equine Passport scheme.
Since 2005, when equine passports became mandatory, 958,000 have been issued. The passport is a method of identification as well as a medical record and ensures that horses treated with veterinary medicines do not enter the human food chain.
“Many substances used in commonly prescribed equine medicines can only be given to horses not intended for human consumption,” says Giles Coley, Dechra’s managing director. “Under the passport scheme, owners must declare whether their horse is intended for human consumption.
The leaflet, which outlines the importance and benefits of the Equine Passport scheme, will be inserted into every box of Equipalazone Powder 100 sachets. It will also be made available for veterinary practices to hand out to their clients.
Practices wishing or order copies of the Equine Passport leaflet should contact Rachel Horton at Dechra on 01743 441 632.
Dechra Veterinary Products has launched a calculator which provides vets with an instant analysis of how much they can save when stocking veterinary licensed generic products over an equivalent.
The new margin calculator enables practices to manipulate their mark-ups for a greater increase in profit while also providing cost savings for clients.
Roger Brown, product manager at Dechra Veterinary Products said: "With the rise of veterinary licensed generic products on the market, our calculator provides practices with an added opportunity to increase their own profitability. This can be achieved through a simple re-calculation based on the purchase price of a product, versus its mark-up and how much they are sold on to clients for. In many circumstances, practices will see an increased profit for themselves and cost reductions for the client – everyone wins!"
The margin and profit calculator compares market prices with Dechra’s own generic range – Veterinary Essentials – to show just how much mark-up can be applied to products without impacting on a client’s budget.
Roger added: "It’s a simple, but very effective calculation. The beauty is that this calculator can be run from any computer and does not require supporting software."
For more information about the margin calculator please contact your local Dechra territory manager or call Rachel Horton on 01743 441 632.
Pfizer, manufacturer of the wormer Strongid™-P has launched a new promotional campaign. Love your horse is based on simple, straightforward and unbiased educational messages to help ensure the optimum health and wellbeing of horses and ponies in the UK.
Pfizer's veterinary adviser Ben Gaskell said: “Simplistically, the three key tools for the horse owner to understand are diagnostics, worming and pasture management. If these tools are used in combination with specialist advice, then the horse owner will be able to provide a sustainable, reliable and cost-effective worm control strategy for their horse.”
At the core of the campaign is a new range of four highly informative and uncomplicated leaflets directed at every type of horse owner: Do you need to worm; Choosing and using the right wormer; Managing your pasture and Worming and Your new horse.
“Each leaflet has been designed to work as a stand-alone piece or can be presented as a smart, matching series of four,” said Helen Shirley, brand manager for Strongid™-P. “The leaflets can be displayed in-store in a distinctive counter-top leaflet dispenser and are supported by eye-catching point of sale materials including posters and balloons." The new campaign packs will be rolled out to all stockists from early June, supported by a dramatic new Love your horse advertisement in national equestrian trade and consumer titles.
The campaign will build up momentum over the summer months and into autumn’s double dosing time with a series of authoritative, no-nonsense features and news stories from Strongid™-P’s veterinary advisor Ben Gaskell.
For further information please email: Strongid-P@pfizer.com
A bad day for Egyptian veterinary surgeon Dr. Ibrahim Samaha from the University of Alexandria, who not only had the misfortune to board an aircraft that was later hijacked, but was also wrongly identified in the media as the hijacker.
Professor Samaha, who, according to Reuters, heads the department of food health at the University, later appeared on BBC Arabic to protest his innocence.
The Cyprus Ministry of Foreign Affairs later identified the real hijacker as Seif Eldin Mustafa (pictured right), about whom an official from Egypt's foreign ministry was reported to have said: "He’s not a terrorist, he’s an idiot. Terrorists are crazy but they aren’t stupid. This guy is." - though this was later denied.
The new award, sponsored by Krka UK, will recognise an exceptional farm vet who has been working in the dairy industry for three to five years and who has contributed significantly to the health and wellbeing of herds under their care.
Sarah Tomlinson, veterinary surgeon at Westpoint Farm Vets in Derbyshire, Technical Director of the TB Advisory Service (TBAS) and recipient of the 2020 Dairy Vet of the Year, said: “In recognising achievement among more recently qualified vets with this new award, Krka is giving the boost every young vet needs to shake off the ‘new grad’ title and instead become an ‘high performing’ vet, judged by their industry peers to be one of the best. Many vets can suffer with imposter syndrome so it is important that we accept positive acknowledgement of our work and our everyday achievements so that we can be rightly proud of what we do.”
More information about the CREAM Awards and the nomination process can be found here: https://www.britishdairying.co.uk/cream-awards-2021/
The BVA Animal Welfare Foundation (BVA AWF) in conjunction with the Veterinary Poisons Information Service (VPIS) has announced the launch of an update of its popular Pets and Poisons - Keeping Your Animals Safe leaflet, first produced in 2004.
Based on information compiled by the VPIS, the leaflet provides a valuable and easy reference guide for owners on preventing poisoning in the home, in the garden or in open spaces along with advice on what to do if you think your animal has been poisoned.
Veterinary practices can obtain batches of 50 leaflets for the waiting room, free of charge (although a donation to AWF is encouraged) directly from the BVA agents Ten Alps on 020 7878 2307 or Louise.walpole@tenalpspublishing.com
Vetoquinol has launched a pain monitoring system along similar lines to those used in humans, which can be used by vets and owners to measure pain over time and assess different treatment strategies in dogs.
According to the company, it is widely accepted that all mammals experience pain1and that under treatment is a big issue. Guidelines in treating human pain issued by NICE state that: 'evidence suggests that pain caused by advanced disease remains under-treated'. Veterinary medicine faces a harder task in recognising and treating pain effectively as it relies on behaviour rather than verbal communication.
In human medicine, Client Specific Outcome Measures have been used to assess treatment strategies focussing on identifying the degree of difficulty performing daily tasks on an individual patient to patient basis. Vetoquinol says its pain monitoring system is based on similar principles.
Robert Simpson, Product Manager for Cimalgex said: "The objective assessment of clinical outcomes are a continuing challenge in veterinary medicine; this is particularly true in chronic painful conditions such as osteoarthritis. Use of our Client Specific Outcome Measures form will allow vets and pet owners to more efficiently assess treatment to ensure that the patient is receiving appropriate analgesia.
The form can be adapted to give bespoke outcome measures which are agreed in consultation with the owners. This activity will increase interaction with pet owners and could increase loyalty to the practice; it could also be really useful in geriatric clinics etc as a method of assessing pain outside of consultations in practices."
To find out more or to request a monitoring pad for your practice, contact your Vetoquinol Territory Manager or call 01280 825424.
A team of top equine vets is aiming to raise £125,000 for the Society for the Protection of Animals Abroad (SPANA) by travelling 3000 miles through Europe by motorbike between 22nd August and 9th September.
Sponsored by Elanco Animal Health, the seven-strong team is planning to travel through Belgium, the Netherlands, Germany, Switzerland, France, Italy, Morocco and Spain and deliver lectures to eight European and African veterinary schools in just two weeks.
Led by Professor Derek Knottenbelt from the University of Liverpool, the team also includes Professor Josh Slater from Royal Veterinary College, Dr John Burford from the University of Nottingham, Dr Caroline Hahn from the University of Edinburgh, Dr Michael Hewetson from the University of Helsinki, Ms Joanne Suthers from the University of Liverpool and Dr Edmund Hainisch from the University of Vienna. They are being supported by Jeremy Hulme, chief executive of SPANA, Nic Van Gelder, fundraising and supporter care administrator at SPANA and Cerian Stephens.
All money raised will provide SPANA with diagnostic and surgical equipment for the charity's veterinary clinics for working animals in Mali and Mauritania and for the further development of the Bamako Disabled Riding Centre in Mali.
Mike Brown, Elanco's UK and Ireland country director said: "We are delighted to be sponsoring the Vets with Horsepower European Tour which will raise vital funds for working animals in some of the world's poorest countries. This is just one of the many worthwhile initiatives we are supporting in 2012 which focus on alleviating world hunger, spearheading agricultural leadership, enhancing the human-animal bond and caring for the environment."
For further information on the Vets with Horsepower European Tour visit www.spana.org/horsepower.
The Pet Food Manufacturers Association (PFMA) has published the results of research which found that veterinary surgeons believe 45% of all pets are overweight.
In addition, 77% of the 180 vets surveyed at the London Vet Show 2013 believe that the pet obesity problem is on the rise.
Meanwhile, 93% of pet owners said they would be concerned to discover their pet is overweight, revealing a sharp divide between vets' and owners' perceptions.
To help spread the word about ideal pet weight, the PFMA will launch a new campaign called #GetPetsFit on 7th May.
Michael Bellingham, Chief Executive of PFMA said: "We need to engage pet owners emotionally, helping them realise that feeding and exercising their pet to the optimum level can result in an extra two years of active life. The #GetPetsFit campaign will provide the perfect opportunity to do this and we hope that with the help of vets, we can work to resolve this important issue."
The PFMA is urging practices to promote good nutrition and a healthy lifestyle. Zara Boland BVSc BE MRCVS, Founder of Vet Voice Ltd says: "It is encouraging that success rates are high for the 78% of UK vets already running companion animal obesity clinics. However, we must continue pushing the health message until overweight pets are no longer seen as the 'norm'. We need widespread recognition of pet obesity to pave the way for positive action."
One way that the PFMA is encouraging practices to get involved is by running Weigh in Wednesdays from 7th May. To help, the organisation has prepared a free kit that contains campaign posters, website banners and client hand-out materials, including Pet Size-O-Meters (for cats, dogs, rabbits and birds), a pet food diary and weight and body condition log. You can either download the kit here: www.pfma.org.uk/weighinwednesday or visit PFMA's homepage and ask for a free pack to be sent to your practice.
FMDMost of you will be aware that IP8 was declared yesterday. This is a farm in the POZ that was slaughtered on suspicion after detection during surveillance visits. This has lead to further slight changes in the boundaries of the PZ and SZ. These were early lesions and initial laboratory results confirm this.
The epidemiology of the spread of FMD in the area north of Egham suggests that cattle on 4 premises in the vicinity of IP8 have been exposed to infection either via possible aerosol or fomite spread and are likely to develop disease. These premises will be culled as dangerous contacts.
BLUETONGUEThe various zones for controlling Bluetongue have now been defined. These are difficult to describe because they use roads etc. as boundaries but detailed maps and description of the boundaries are available at:
http://www.defra.gov.uk/animalh/diseases/notifiable/bluetongue/pdf/declaration-bt-pzcz290907.pdf
When farms straddle a road that is a boundary the whole of the farm is classed as being in the zone. It may be possible to put parts of a holding that is outside the zone as a separate unit with consultation with local Animal Health office.
The movement restrictions between the various FMD and BT zones are available at
http://www.defra.gov.uk/animalh/diseases/notifiable/bluetongue/movements/index.htm
Defra are worried that farmers are not reporting cases of BT because they feel there is nothing that can be done so why bother. It is still a notifiable disease and there is a need to monitor spread for various trade implications. There are, of course, likely to be welfare considerations with clinically affected cases. These will need to be addressed with veterinary consultation and may involve symptomatic treatment or euthanasia.
The prevalence of the disease in infected herds/flocks is still low with 1:53 and 1:190 being affected on surveillance.
Intervet/Schering-Plough has launched Vectin chewable tablets, an ivermectin wormer for horses which is administered as a treat straight from the hand rather than in the traditional paste or granule formulation.
According to the company, syringe handling, horse acceptance and the tendency to spit out some or all of the paste are common problems reported by owners when worming their horses, and more than 55% admit that these issues can result in a mixture of emotions, including frustration, anxiety and upset.
Field studies with Vectin showed more than 70% spontaneous acceptance by horses and the simple calculation of one tablet for every 110kg of a horse or foal's bodyweight helps to reduce wastage as unused tablets can be stored away for future use.
Pharmacokinetics studies have demonstrated improved bioavailability (AUC) and maximal concentration (Cmax) when compared with an equivalent competitor ivermectin paste formulation. Trials have also shown that a more consistent blood concentration of ivermectin when given as a chew which could potentially limit the chance of inducing resistance.
Intervet/Schering Plough says that used as part of a strategic worming plan, Vectin chewable tablets control potentially a wide range of endoparasites including small and large strongyles, stomach worms, cutaneous worms and stomach bots.
Vectin chewable tablets are available as a seven-tablet blister pack, perfect for treating a horse or a couple of ponies. For yards, a tub of 60 tablets is available, containing enough to dispense product for worming approximately 12 horses.
Vectin chewable tablets are recommended for use alongside Pyratape P and Panacur in Intervet/Schering-Plough Animal Health's Active3 worming plan, a strategic three-year approach to rotating wormers in order to minimize the risk of resistance developing. Visit http://www.intervet.co.uk/ for a copy of the three-year plan.
The BVA has welcomed an update report on dog breeding issues by the Associate Parliamentary Group for Animal Welfare (APGAW).
Working with a small group of stakeholders including the British Veterinary Association, Dogs Trust, Kennel Club and RSPCA, this report looks at what has been done since the first APGAW report in late 2009 and the airing of Pedigree Dogs Exposed (2008) and Pedigree Dogs Exposed: Three Years On (2012).
BVA Past President Harvey Locke said: "The BVA fully endorses the recommendations and practical solutions offered by this timely report."
Mr Locke drew attention to a number of points in the report's action plan including:
Mr Locke added: "I am pleased that the APGAW report recognises the vital role that education plays in tackling irresponsible dog ownership and would very much like to see the inclusion of animal welfare as part of the core curriculum.
"I am also delighted that the group recognises the value of a puppy contract. The BVA Animal Welfare Foundation and RSPCA have recently launched a puppy contract and puppy information pack (PIP) which arms buyers with the knowledge to give themselves the best chance of getting a fit, healthy and happy, well socialised pet to join their household. The contract and PIP have also been designed to help good breeders demonstrate the care and attention they have devoted to their puppies' breeding and upbringing.
"Much work has already been undertaken to improve dog breeding but there is much more to be done and the momentum must not be lost. I am most grateful to Neil Parish MP, chairman of APGAW, for his commitment to producing this report. It is an excellent means of keeping the issue high on the agenda by encouraging wider dialogue and debate within Parliament and in the EU."
Zoetis Business Consulting has announced the launch of a new website to showcase the services it provides for veterinary practices to help them grow their businesses.
Centering on three main areas of a practice's business - clinical experience, business performance and marketing - the website explains how the business consulting team uses quantitative and qualitative evidence to understand a practice's challenges in order to design and deliver bespoke solutions.
Nick Steele, national consulting manager said: "Zoetis Business Consulting has really taken off as more and more veterinary practices realise the benefits of working in partnership with our consultants. Since we are also launching new services, such as Profit Solver to the mix, the time was right to launch a new website showcasing how we work with practices."
For more information visit http://www.zoetis.co.uk/businessconsulting.
Zoetis has announced that it has upscaled production of Apoquel, the oral therapy for the treatment of canine pruritus, and it is now available to all UK vet practices on unlimited distribution.
The company says that there was unprecedented demand for Apoquel following its launch last year, so it had to introduce an allocation system to ensure that those dogs that had started on the product were able to remain on it for as long as their vet deemed appropriate.
During this time, Zoetis focused on strengthening its manufacturing capacity to make the product more widely available.
Apoquel is the first Janus Kinase (JAK) inhibitor approved for veterinary use. Zoetis says it provides rapid and sustained relief of pruritus and improves skin lesions. Its novel mechanism of action on the JAK enzyme is specifically designed to target the pruritogenic and pro-inflammatory pathways involved in the itch cycle. This, says the company, allows effective reduction of allergic itch regardless of its cause as well as improvement of skin lesions associated with allergic skin diseases and atopic dermatitis.
Ned Flaxman, companion animal business unit director at Zoetis said: “We are very grateful to all our veterinary customers for bearing with us through this product shortage. Over the past 18 months we have incorporated a variety of safeguards to ensure that Apoquel supply will better align with demand. We have reduced the length of time it takes to manufacture Apoquel and added further production capacity.
“It’s been a very long 18 months for everyone involved but we’re looking forward to a very good Christmas and New Year with Apoquel fully back in stock and we’d like to thank all of our customers for their patience.”
For more information, visit www.zoetis.co.uk/apoquel.
The collaborative study, which was sponsored by Norbrook, involved each practice blood testing a cohort of six lambs on 25 individual farms from 16 weeks of age, to look for evidence of antibodies to liver fluke.
Only 11 farms had positive results in the period from June, up to December, with most only showing one or two lambs out of the six sero-converting later in the year. Even farms located reasonably close by showed positive cases months apart.
Mark Thompson of Craven Farm Vets in Yorkshire said, “I did not expect to see positive results as late in the year. I expected a positive result earlier (September/October) as the farm is a very wet farm with a long-standing issue with fluke. Also, the weather in the area has been ideal for the intermediate host and fluke development on the pasture.”
Emily Baxter of Drove Farm Vets in Wiltshire said she thinks there is scope to use the results to improve the timing of dosing with flukicides and more responsible use: “We will use the results from this year’s testing to re-evaluate the farm’s fluke control protocol which will help reduce the level of use of flukicides earlier in the season for years with similar weather patterns and assist in planning of strategic grazing.
"We’re looking forward to continuing our work this year, no two years are ever the same, that’s why monitoring is so important. It will allow both ourselves and our clients to build up a picture over time of what’s happening not only on their individual farms, but potentially down to field level! This will allow us to provide more conclusive recommendations. For now, it’s clear that testing has great promise as a means to provide tailored advice to farms on how to control fluke and use the flukicides available to us responsibly.”
Emily says it’s important that farmers do not stop using flukicides based on the results of this study nor assume that there is less risk: “We all know how significant the losses from acute and chronic fascioliasis can be. We therefore encourage farmers to talk to their vet before they change their flukicide treatment protocols and discuss the possibility of using serology as an adjunct to determine how and when they treat.”
Veterinary professionals can find out more about the fluke sentinel project at https://xlvets-farm.co.uk/fluke-sentinel or the XLVets community at https://www.xlvets.co.uk/the-boss/.
The British Occupational Hygiene Society (BOHS) has announced the publication of a book on controlling skin exposure and wet work. The book aims to fill a knowledge gap about dermal exposure risk management in workplaces which are particularly affected, such as veterinary practices.
The consequences of a failure to adequately control dermal exposure to hazardous agents do not always become apparent until years after exposure, and because of this, many employers are either ignorant of the consequences or ignore the potential for ill-health until it is too late. In Great Britain, over 29,000 people are suffering from work-related skin disease and every year over 3,500 new cases are reported. Alongside this, many workers are unaware of the ways in which skin comes into contact with chemicals, or how dermal exposure can contribute to inadvertent inhalation and ingestion exposure.
Healthcare workers are susceptible. Vets and nurses are, for example, at risk from disinfectants, detergents, wet-work, latex gloves, anaesthetics, antibiotics and antiseptics, phenothiazines, formaldehyde, glutaraldehyde and liquid chloroxylenol.
The book provides an introduction to the structure and functions of the skin, information about the diseases caused by dermal exposure and the occupations and chemicals involved, regulatory requirements related to dermal exposure at work, exposure and risk assessment, and risk management strategies. It is both comprehensive and accessible, and clearly illustrated with photographs, figures and tables throughout, ensuring that it will be of practical use. As a result, BOHS believes that it will make an important contribution to increasing knowledge about control of dermal exposure, and encourage more effective control measures to be introduced in workplaces.
‘Controlling Skin Exposure to Chemicals and Wet-Work' is available for £19.99 and can be purchased on-line via RMS Publishing, www.rmspublishing.co.uk/BOHS.html and Amazon, or by posting/faxing the order form which can be downloaded from the Publications section of the BOHS website.
A series of exchanges between pilots and control towers, which you might find amusing. Would be nice to have some veterinary equivalents, so do feel free to comment beneath this story with any quick-witted exchanges you've heard between vets and vets / nurses / clients.
San Jose Tower to a DC-10 that had come into land too fast, and thus had an exceedingly long roll out after touching down:"American 751, make a hard right turn at the end of the runway, if you are able. If you are not able, take the Guadeloupe exit off Highway 101, make a right at the lights and return to the airport." ***************************************************************
Tower: "TWA 2341, for noise abatement turn right 45 degrees." TWA 2341: "Center, we are at 35,000 feet. How much noise can we make up here?" Tower: "Sir, have you ever heard the noise a 747 makes when it hits a 727?" ***************************************************************
Tower: "Eastern 702, cleared for takeoff, contact Departure on frequency 124.7" Eastern 702: "Tower, Eastern 702 switching to Departure. By the way,after we lifted off we saw some kind of dead animal on the far end of the runway." Tower: " Continental 635, cleared for takeoff behind Eastern 702, contact Departure on frequency 124.7. Did you copy that report from Eastern 702?" BR Continental 635: "Continental 635, cleared for takeoff, roger; and yes, we copied Eastern... we've already notified our caterers." ****************************************************************
A BA 747, callsign Speedbird 206 landed at Frankfurt aiport and was just pulling clear of the runway
Speedbird 206: "Frankfurt, Speedbird 206 clear of active runway." Frankfurt ground: "Speedbird 206. Taxi to gate Alpha One-Seven." The BA 747 pulled onto the main taxiway and slowed to a stop. Frankfurt ground: "Speedbird 206, do you not know where you are going?" Speedbird 206: "Stand by, ground, I'm looking up our gate location now." Frankfurt ground (with quite arrogant impatience): "Speedbird 206, have you not been to Frankfurt before?" Speedbird 206: "Er yes, just the once. It was 1944 ... We didn't land."
Improve International has announced the launch of a new General Practitioner Certificate in Dermatology: GPCert (Derm).
The company says the programme aims to help vets develop their knowledge of dermatology and to assist them in applying these newly learned skills in their everyday dermatology cases.
David Babington MRCVS (pictured right), Managing Director of Improve International said: "Patients with skin problems attend practices almost on a daily basis, making the successful diagnosis and management of skin disease a major component of small animal work and an important way to build client satisfaction and loyalty.
"Our new modular programme offers a thorough, informed case-based approach to dermatology. Through lectures, case discussions and, where appropriate, practical sessions, delegates will learn how to approach dogs, cats and exotic patients presenting with various manifestations of skin disease in a logical and scientific manner."
The GPCert (Derm) comprises 14 taught modules and can be completed over one to two years. The first module on this programme will start in March 2015.
For further information, visit www.improveinternational.com or call 01793 759159.
Kate (pictured right) was confirmed as the 150th RCVS President at the College’s 2021 Annual General Meeting, which took place last Friday. Kate’s investiture makes her the 10th female President of the RCVS and the first to lead an all-female presidential team with Senior Vice-President Mandisa Greene and Junior Vice-President Melissa Donald.
Kate has been an elected member of RCVS Council from 2015 to 2019 and then from 2020 onwards, and brings with her a bank of professional experience having worked in clinical farm practice, in the pharmaceutical industry and as a senior civil servant in non-veterinary roles, including as Principal Private Secretary to three Secretaries of State for Scotland.
She’s a graduate from the Royal (Dick) School of Veterinary Studies at the University of Edinburgh and during her time on RCVS Council has chaired the Standards Committee and been a member of the Legislation Working Party. She currently chairs the Preliminary Investigation Committee /Disciplinary Committee Liaison Committee and sits on the Education Committee, Registration Committee, VN Council, Primary Qualifications Subcommittee and the Environmental & Sustainability Working Party.
During her first speech as RCVS President, Kate spoke about how experiences of loneliness early in her veterinary career, when she was working in rural farm vet practice, has led her to have a deep understanding of the importance of connection, something which has been reinforced by the coronavirus pandemic.
She said: “The Covid pandemic has demonstrated the value of connections for our mental health and wellbeing. Social distancing has spotlighted in fluorescent pinks, blues and greens the need for social connections. When hungry we eat, thirsty we drink, when we feel lonely we need to connect.
“And that starts with connecting with ourselves, nurturing our minds and bodies, building our sense of self and resilience. I am passionate about initiatives including the RCVS Mind Matters Initiative and Vetlife that support our professions.
“Connections within the professions have been fundamental to my career, providing opportunities to collaborate, extend my knowledge and forge support networks. I look forward to building stronger connections with vets in the UK and abroad, including the Federation of Veterinarians in Europe. I’m so excited about the energy, new connections and networks springing up in the profession.
“I’ve worked in non-veterinary roles where I’ve had the opportunity to make new connections and share knowledge across professional disciplines.
“Pre-pandemic I attended a seminar on domestic violence. Speakers from social services said how hard it was to identify victims of domestic violence who were too scared to report. I informed the room about the Links Group, which works hard to raise awareness of the connection between the abuse of animals and people. Sadly, there are still silos, disconnections between well-meaning professionals. That proves to me the critical role of vets in human health and welfare by reporting animals they suspect of non-accidental injury.”
She concluded her speech (which is available to read in full at www.rcvs.org.uk/features) by saying: “I am excited about my presidential year, thankful for my connections, my iceberg of support. I’m thankful for the wise counsel of past Presidents especially Mandisa Greene and Niall Connell. My priority is to encourage Connections that Count, making sure we look after ourselves so that we can build vibrant purposeful and powerful connections across ours and allied professions for the good of animal and human health and welfare, for our communities, society and the environment.
“My aim this year? To amplify and extend the reach of the veterinary voice.”
The company has set up the Group Veterinary Medical Board (GVMB) Research Fund to offer practical support and financial assistance.
Deputy Chief Medical Officer Alistair Cliff (pictured right), said: "We introduced funding for research across our European Group at the beginning of this year and have been overwhelmed by the interest this has received. We understand the importance of these opportunities for professional development and also an individual’s job satisfaction.
“We believe it is incumbent upon us to increase this support for research to contribute to the advancement of knowledge, the development of our teams and our value as an employer. Ensuring our teams are content, with a diverse range of ways to develop, is important in allowing us to continue to attract the best people in the profession.
The GVMB Research Fund made its first awards in June 2021. Seven grants were provided to research teams from three countries – the UK, The Netherlands and France. In total, the funding will benefit some 21 researchers working as interns, residents, referral clinicians and specialists from a variety of different settings.
Chief Medical Officer Amanda Boag said: "It is incredibly satisfying to be able to provide support to our teams at critical points of their professional development. In some cases, funding has been provided to experienced researchers looking to contribute yet more to the understanding within their respective disciplines. In other examples, we have supported interns, who are at the very beginning of that journey and at a stage where funding can be difficult to secure.”
She added: “With additional interest from several general practitioners and nurses, the fund has quickly become a significant benefit to working for IVC Evidensia."
The GVMB also provides resources to guide teams on study design, ethical requirements, and statistical support. Less experienced researchers can access a network of Research Partners - a group of experienced clinicians from around Europe who have volunteered their own time to mentor colleagues through a collaborative approach to a project.